LAKE FOREST, Ill., July 15, 2015 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, and a global leader in biosimilars, will release its second-quarter 2015 results on Wednesday, July 29, 2015, before the U.S. stock market open. Given the company's pending merger with Pfizer Inc., Hospira will not be holding a conference call.
Hospira intends to file its Quarterly Report on Form 10-Q for the fiscal second quarter ended June 30, 2015 with the U.S. Securities and Exchange Commission (SEC) on the same day. As is the company's standard practice, both documents will be accessible in the Investor Relations section of Hospira's website at www.hospirainvestor.com.
About Hospira Hospira, Inc. is the world's leading provider of injectable drugs and infusion technologies, and a global leader in biosimilars. Through its broad, integrated portfolio, Hospira is uniquely positioned to Advance Wellness™ by improving patient and caregiver safety while reducing healthcare costs. The company is headquartered in Lake Forest, Ill. Learn more at www.hospira.com.
SOURCE Hospira, Inc.